Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.
Open Access
- 1 September 1979
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 150 (3) , 432-444
- https://doi.org/10.1084/jem.150.3.432
Abstract
To produce alloantibodies [allo-Ab] to cytotoxic T[thymus-derived]-cell receptors, hyperimmune anti-lymphocyte antisera were raised in mice of various strain combinations and were tested for their ability to block allogeneic cell-mediated lymphocytotoxicity (CML) in the absence of complement at the T killer cell level. Most sera failed to show any significant and reproducible inhibitory effects. Among C3H anti-B10.BR antisera, some sera could significantly inhibit CML. This effect was attributable to Ab reacting with the killer population rather than the target cells, because the sera inhibited B10 anti-C3H CML but not C3H anti-B10 CML. Among mouse strains tested, A/J, BALB/c, B10 and B6 strains were sensitive to the inhibitory effect of the sera whereas AKR, CBA, C3H and DBA/2 strains were insensitive. This sensitivity of killer cells to the inhibitory effect correlated well with the strain distribution of the Lyt-2.2 antigen. In the presence of complement, these same sera were toxic to 100% of spleen cells of AKR, BALB/c, B10 and DBA/2 strains, with comparable cytotoxic titers. The inhibitory activity of the sera could not be explained by non-specific effects of high-titered Ab. To study the relationship between the antigen(s) responsible for the blocking effect and Lyt-2-linked genes, killer cells from Lyt-2 congenic strains were tested and conventional anti-Lyt-2.2 antisera were raised in an appropriate congenic strain combination. Killer cells from B6, but not from B6.Ly2.1 animals, were significantly sensitive to the blocking effects of the inhibitory C3H anti-B10.BR sera. The conventional anti-Lyt.2.2 sera did produce CML blocking, although there was no apparent correlation between such blocking and the anti-Lyt-2.2 cytotoxic titer. The target molecules responsible for blocking of killer cells may be encoded or regulated by genes that are closely linked to or identical with Lyt-2.This publication has 19 references indexed in Scilit:
- On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?The Journal of Experimental Medicine, 1978
- INVITRO STUDIES OF RABBIT IMMUNE SYSTEM .6. RABBIT ANTI-MOUSE CYTOTOXIC T EFFECTOR CELLS ARE INHIBITED BY ANTI-RABBIT T-CELL SERUM IN ABSENCE OF COMPLEMENT1978
- Studies on the Nature of the Relationship Between Ia Antigens and Fc Receptors on Murine B LymphocytesThe Journal of Immunology, 1977
- Cytotoxic T Lymphocyte Membrane Components: An Analysis of Structures Related to FunctionPublished by Springer Nature ,1977
- Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses.The Journal of Experimental Medicine, 1976
- Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses.The Journal of Experimental Medicine, 1976
- Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.The Journal of Experimental Medicine, 1975
- Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen.The Journal of Experimental Medicine, 1975
- Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.The Journal of Experimental Medicine, 1975
- INHIBITION OF SPECIFIC CELL-MEDIATED CYTOTOXICITY BY ANTI-T-CELL RECEPTOR ANTIBODYThe Journal of Experimental Medicine, 1974